Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$183808.0.

  • Neuraxis' Cash from Financing Activities fell 7143.23% to -$183808.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year increase of 5965.29%. This contributed to the annual value of $9.7 million for FY2024, which is 4785.18% up from last year.
  • According to the latest figures from Q3 2025, Neuraxis' Cash from Financing Activities is -$183808.0, which was down 7143.23% from $5.5 million recorded in Q2 2025.
  • In the past 5 years, Neuraxis' Cash from Financing Activities registered a high of $5.5 million during Q2 2025, and its lowest value of -$183808.0 during Q3 2025.
  • Moreover, its 4-year median value for Cash from Financing Activities was $807543.0 (2022), whereas its average is $1.8 million.
  • In the last 5 years, Neuraxis' Cash from Financing Activities soared by 41948.26% in 2024 and then crashed by 10517.34% in 2025.
  • Over the past 4 years, Neuraxis' Cash from Financing Activities (Quarter) stood at $510009.0 in 2022, then surged by 284.88% to $2.0 million in 2023, then surged by 164.61% to $5.2 million in 2024, then crashed by 103.54% to -$183808.0 in 2025.
  • Its Cash from Financing Activities was -$183808.0 in Q3 2025, compared to $5.5 million in Q2 2025 and -$69845.0 in Q1 2025.